US Defense rolls out testosterone screening for troops, spotlighting age‑related health policy, military readiness culture, and broader occupational health inequities
Original framing: “Trump defence chief Hegseth unveils plan to test US troops for low testosterone” — South China Morning Post
Women, transgender, and lower‑rank service members have been largely excluded from the policy discourse, despite evidence that hormonal interventions affect them differently. Veteran advocacy groups and frontline medical staff have raised concerns about consent, side‑effects, and the potential for coercive treatment environments.
The testosterone screening policy reflects a longstanding militaristic tendency to medicalize individual performance, privileging narrow biochemical metrics over holistic well‑being.
By foregrounding Indigenous, historical, and cross‑cultural insights, we see that alternative models—rooted in community health, ethical participation, and robust longitudinal research—can sustain readiness without resorting to potentially coercive hormone therapy. Implementing a participatory occupational health framework, supported by international knowledge exchange and rigorous data, aligns military effectiveness with the rights and health of all service members, especially those historically marginalized.